The authors of the above-listed article would like to make the following corrections: In Table 2, the “P value” column heading should be changed to “LOD score.” In Table 3, markers “D3S2394” and “D3S2419” should appear as “D3S2398”
and “D3S2418,” respectively.
Nathan L. Alderson’s name was incorrectly listed in the above article in the September issue of Diabetes. The correct author list is shown above.
On page 2891 of the above-listed article, seven lines from the bottom of the first complete paragraph, reference citations
17 and 18 should be 29 and 30, respectively. In addition, due to duplicate citations in the reference list of refs. 2 (repeated
as 29) and 11 (repeated as 19), all references subsequent to ref. 18 are mismatched in the text. Thus, the correct listing
of refs. 19–50 is shown below.
REFERENCES
Kraegen EW, James DE, Storlien LH, Burleigh KM, Chisholm DJ: In vivo insulin resistance in individual peripheral tissues of
the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration.
Diabetologia
29:
192
–198,
1986
Kraegen EW, James DE, Bennett SP, Chisholm DJ: In vivo insulin sensitivity in the rat determined by euglycemic clamp.
Am J Physiol
245:
E1
–E7,
1983
Kraegen EW, James DE, Jenkins AB, Chisholm DJ: Dose-response curves for in vivo insulin sensitivity in individual tissues
in rats.
Am J Physiol
248:
E353
–E362,
1985
Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW, Cooney GJ: Long-chain acyl-CoA esters as indicators of lipid
metabolism and insulin sensitivity in rat and human muscle.
Am J Physiol
279:
E554
–E560,
2000
Chan TM, Exton JH: A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue
or isolated hepatocytes.
Anal Biochem
71:
96
–105,
1976
McGarry JD, Stark MJ, Foster DW: Hepatic malonyl-CoA levels of fed, fasted and diabetic rats as measured using a simple radioisotopic
assay.
J Biol Chem
253:
8291
–8293,
1978
Saha AK, Kurowski TG, Colca JR, Ruderman NB: Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on
malonyl-CoA and diacylglycerol.
Am J Physiol
267:
E95
–E101,
1994
Vavvas D, Apazidis A, Saha AK, Gamble J, Patel A, Kemp BE, Witters LA, Ruderman NB: Contraction-induced changes in acetyl-CoA
carboxylase and 5′-AMP-activated kinase in skeletal muscle.
J Biol Chem
272:
13255
–13261,
1997
Tomas E, Sevilla L, Palacin M, Zorzano A: The insulin-sensitive GLUT4 storage compartment is a postendocytic and heterogeneous
population recruited by acute exercise.
Biochem Biophys Res Commun
284:
490
–495,
2001
Carlson CL, Winder WW: Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise.
J Appl Physiol
86:
669
–674,
1999
Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, Holloszy JO: Activation of AMP-activated protein kinase increases mitochondrial
enzymes in skeletal muscle.
J Appl Physiol
88:
2219
–2226,
2000
Buhl ES, Jessen N, Schmitz O, Pedersen SB, Pedersen O, Geoffrey D. Holman, Lund S: Chronic treatment with 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside
increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner.
Diabetes
50:
12
–17,
2001
Delp MD, Duan C: Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle.
J Appl Physiol
80:
261
–270,
1996
James DE, Jenkins AB, Kraegen EW: Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies
in rats.
Am J Physiol
248:
E567
–E574,
1985
Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels
are inversely related to insulin action.
Diabetes
46:
983
–988,
1997
Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N: Association of
nonalcoholic fatty liver disease with insulin resistance.
Am J Med
107:
450
–455,
1999
Virkamaki A, Korsheninnikova E, Seppala-Lindroos A, Vehkavaara S, Goto T, Halavaara J, Hakkinen AM, Yki-Jarvinen H: Intramyocellular
lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling
pathways in human skeletal muscle.
Diabetes
50:
2337
–2343,
2001
Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM: The role of lipids in the pathogenesis of muscle insulin resistance
and beta cell failure in type II diabetes and obesity.
Exp Clin Endocrinol Diabetes
109:
S189
–S201,
2001
Thompson AL, Cooney GJ: Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced
insulin resistance.
Diabetes
49:
1761
–1765,
2000
Faergeman NJ, Knudsen J: Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling.
Biochem J
323:
1
–12,
1997
Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL: Involvement of protein kinase C in human skeletal muscle insulin resistance
and obesity.
Diabetes
49:
1353
–1358,
2000
Ruderman NB, Saha AK, Vavvas D, Witters LA: Malonyl-CoA, fuel sensing, and insulin resistance.
Am J Physiol
276:
E1
–E18,
1999
Brown NF, Hill JK, Esser V, Kirkland JL, Corkey BE, Foster DW, McGarry JD: Mouse white adipocytes and 3T3-L1 cells display
an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during differentiation: inter-tissue and
inter-species expression of CPT I and CPT II enzymes.
Biochem J
327:
225
–231,
1997
Holmes BF, Kurth-Kraczek EJ, Winder WW: Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase,
and glycogen in muscle.
J Appl Physiol
87:
1990
–1995,
1999
Fisher JS, Gao J, Han DH, Holloszy JO, Nolte LA: Activation of AMP kinase enhances sensitivity of muscle glucose transport
to insulin.
Am J Physiol
282:
E18
–E23,
2002
Richter EA, Garetto LP, Goodman MN, Ruderman NB: Muscle glucose metabolism following exercise in the rat: increased sensitivity
to insulin.
J Clin Invest
69:
785
–793,
1982
Garetto LP, Richter EA, Goodman MN, Ruderman NB: Enhanced muscle glucose metabolism after exercise in the rat: the two phases.
Am J Physiol
246:
E471
–E475,
1984
Derave W, Ai H, Ihlemann J, Witters LA, Kristiansen S, Richter EA, Ploug T: Dissociation of AMP-activated protein kinase activation
and glucose transport in contracting slow-twitch muscle.
Diabetes
49:
1281
–1287,
2000
Aschenbach WG, Fujii N, Howlett KF, Sakamoto K, Goodyear LJ: Acute AICAR treatment elicits fiber-type specific responses in
glycogen metabolism in vivo (Abstract).
Diabetes
50 (Suppl.1):
A60,
2001
Winder WW: Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle.
J Appl Physiol
91:
1017
–1028,
2001
Lochhead PA, Salt IP, Walker KS, Hardie DG, Sutherland C: 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin
on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase.
Diabetes
49:
896
–903,
2000
Fiedler M, Zierath JR, Selén G, Wallberg-Henriksson H, Liang Y, Sakariassen KS: 5-aminoimidazole-4-carboxy-amide-1-β-D-ribofuranoside
treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice.
Diabetologia
44:
2180
–2186,
2001
Tan C, Tuch BE, Tu J, Brown SA: Role of NADH shuttles in glucose-induced insulin secretion from fetal β-cells. Diabetes 51:2989–2996, 2002
On page 2995, the words “and is restored to normal” were inadvertently omitted from the last sentence of the first complete
paragraph. The correct sentence is shown below.
This is consistent with reports that mGPDH activity is decreased in islets of humans (18) and animals with type 2 diabetes
(17,33) and is restored to normal when blood glucose is normalized (34).
